Mind & Spirit
Invest in companies transforming mental healthcare through innovative treatments and technologies. These carefully selected stocks represent leaders in psychedelic therapeutics, telehealth platforms, and neurological treatments addressing the growing global demand for mental wellness solutions.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
This collection targets the rapidly expanding mental health market by focusing on companies developing breakthrough treatments and technologies. From novel psychedelic compounds to telehealth services, these stocks represent the future of brain and emotional wellness in an increasingly destigmatized field.
What You Need to Know
This portfolio blends emerging biotechs with established medical companies creating next-generation mental health treatments. The group benefits from powerful trends including regulatory evolution, virtual care adoption, and growing acceptance of alternative therapies for psychological conditions.
Why These Stocks
We've handpicked companies with clear missions to advance mental healthcare through innovation. This selection includes both pioneering startups developing novel compounds and established firms with strong market positions, all poised to address large, underserved patient populations.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+263.89%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 263.89% over the next year.
Stocks Rated Buy by Analysts
11 of 14 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 3.3% return last month.
Why You'll Want to Watch These Stocks
Breaking Mental Health Barriers
These companies are pioneering treatments once considered impossible, creating therapies that could help millions with treatment-resistant conditions like severe depression and PTSD.
Regulatory Winds Shifting
A fundamental change in how regulators view novel therapeutics is quickly unlocking massive new markets, especially for previously restricted compounds showing promise for mental health.
The Next Healthcare Revolution
Mental health is becoming as important as physical health, with spending expected to surge as stigma fades and innovative digital platforms make treatment more accessible than ever before.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Consumer Caution: Value Prevails
A sharp drop in consumer sentiment, driven by persistent inflation fears, signals a potential shift in household spending. This theme focuses on companies poised to benefit as consumers prioritize essential goods and seek value.
Refining a New Opportunity: Venezuelan Crude Returns
Following a renewed U.S. license, Chevron has resumed oil shipments from Venezuela, creating a new supply of heavy crude for the market. This development presents a potential investment opportunity in U.S. refiners and logistics firms positioned to benefit from this strategic shift.
Consumer Strength: The Retail Rebound
A surprising surge in U.S. retail sales, driven by strong automotive and home furnishing purchases, signals continued consumer strength despite economic headwinds. This theme focuses on retailers and manufacturers in these key discretionary sectors that are benefiting from the robust consumer demand.
Frequently Asked Questions
Everything you need to know about the product and billing.